ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå º¸°í¼­ : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°(2025-2033³â)
Japan Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2025-2033
»óǰÄÚµå : 1609693
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 122 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,255,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,674,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,094,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå ±Ô¸ð´Â 2024³â 2¾ï490¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 6¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â »çÀÌ 11.42%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¹× µ¥ÀÌÅÍ »çÀ̾ð½ºÀÇ °ý¸ñÇÒ¸¸ÇÑ ¼ºÀå°ú ÇÔ²² »õ·Î¿î Ä¡·á Àü·«ÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : ¼­·Ð

Á¦5Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå ±¸µµ

Á¦6Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : Á¦Ç°º° ºÐ¼®

Á¦7Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : ¿ëµµº° ºÐ¼®

Á¦8Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ºÐ¼®

Á¦9Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : °æÀï ±¸µµ

Á¦10Àå ÁÖ¿ä ±â¾÷ °³¿ä

Á¦11Àå ÀϺ»ÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º ½ÃÀå : ¾÷°è ºÐ¼®

Á¦12Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Japan oligonucleotide synthesis market size reached USD 204.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 603.0 Million by 2033, exhibiting a growth rate (CAGR) of 11.42% during 2025-2033. The widespread adoption of novel therapeutic strategies, coupled with significant growth of bioinformatics and data science, is primarily driving the market growth.

Oligonucleotide synthesis is the procedure for constructing short DNA or RNA molecules, known as oligonucleotides, with a specific sequence. These sequences can vary in length from just a few bases to approximately 200 nucleotides. This process is typically carried out through chemical synthesis in a controlled laboratory setting, often utilizing solid-phase phosphoramidite chemistry. In this approach, nucleotides are sequentially added to a growing chain, with each addition involving a series of chemical reactions. This technology allows scientists to create tailor-made oligonucleotides for a range of applications, including gene synthesis, polymerase chain reaction (PCR), gene editing tools like CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have greatly accelerated research in genomics and molecular biology, playing a pivotal role in numerous breakthroughs in medical and biological research.

Japan Oligonucleotide Synthesis Market Trends:

The Japanese market for oligonucleotides is primarily propelled by the increasing incidence of genetic diseases within the population. This necessitates the exploration of novel therapeutic approaches, with a significant role being played by oligonucleotide-based therapies. For example, therapies utilizing small interfering RNAs (siRNAs) and antisense oligonucleotides are being researched and applied in the treatment of genetic disorders like Duchenne muscular dystrophy and spinal muscular atrophy. Consequently, the growing prevalence of genetic diseases is driving demand not only in Japan but also on a wide scale. Furthermore, the expansion of bioinformatics and data science is directly impacting the oligonucleotide synthesis sector. The increasing capacity to analyze extensive genomic datasets is positively influencing the market by generating greater demand for the synthesis of innovative oligonucleotides. Additionally, oligonucleotides, particularly antisense oligonucleotides, have proven effective in epigenetic research and therapy, facilitating gene expression modulation and contributing to a favorable market outlook. Moreover, collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become crucial drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborative efforts are expected to fuel the regional market over the forecasted period.

Japan Oligonucleotide Synthesis Market Segmentation:

Product Insights:

Application Insights:

End Use Insights:

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Japan Oligonucleotide Synthesis Market - Introduction

5 Japan Oligonucleotide Synthesis Market Landscape

6 Japan Oligonucleotide Synthesis Market - Breakup by Product

7 Japan Oligonucleotide Synthesis Market - Breakup by Application

8 Japan Oligonucleotide Synthesis Market - Breakup by End Use

9 Japan Oligonucleotide Synthesis Market - Competitive Landscape

10 Profiles of Key Players

11 Japan Oligonucleotide Synthesis Market - Industry Analysis

12 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â